Influence of the Brownie Breast Shield on the Dynamics of Milk Removal
BDM
1 other identifier
interventional
49
1 country
1
Brief Summary
The purpose of this study is to investigate the efficacy of breast drainage of the healthy breast with the new Medela pump set breast shield (Brownie). The objective of the study is to verify the Brownie breast shield to be non-inferior to the current PersonalFit breast shield in emptying the healthy lactating breast.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 15, 2017
CompletedFirst Posted
Study publicly available on registry
March 27, 2017
CompletedStudy Start
First participant enrolled
March 31, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 19, 2017
CompletedFebruary 10, 2020
February 1, 2018
6 months
March 15, 2017
February 7, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PAMR
Breast drainage, determined by the metric percent of available milk removed (PAMR).
7-21 days
Secondary Outcomes (4)
Milk volume
After 15 minutes of controlled pumping with the test or comparator device. Each participant will pump twice with a "washout period" of 7-21 days in between the corresponding occasions.
Mid fat content
After 15 minutes of controlled pumping with the test or comparator device. Each participant will pump twice with a "washout period" of 7-21 days in between the corresponding occasions.
Hind fat content
After 15 minutes of controlled pumping with the test or comparator device. Each participant will pump twice with a "washout period" of 7-21 days in between the corresponding occasions.
Device usability
After 15 minutes of controlled pumping with the test or comparator device. Each participant will pump twice with a "washout period" of 7-21 days in between the corresponding occasions.
Study Arms (2)
Group A
EXPERIMENTALDrainage of the lactating breast using: PersonalFit - Breast shield \& Brownie - Breast shield Breast shields are each to be used for 15 min pumping with the symphony breastpump
Group B
EXPERIMENTALDrainage of the lactating breast using: Brownie - Breast shield \& PersonalFit - Breast shield Breast shields are each to be used for 15 min pumping with the symphony breastpump
Interventions
Subjects are to pump 15 min with the comparator device
Subjects are to pump 15 min with the investigational device
Eligibility Criteria
You may qualify if:
- Subject ≥ 18 years old
- Infant is ≥1 and ≤6 month old
- Subject is predominantly breastfeeding (80% of all feeds, i.e. ≤150 ml formula/day or equal representative amount of solid food)
- The subject agrees to pump or feed the last time a minimum of 3 hours before the start of the pumping session at the study site
- The subject agrees to photographs of the breast and upper body (no face)
- The subject agrees to perform a 24 hour milk production at home, inclusive weighing the Infant before and after each feeding
- The subject agrees to collect \~2 ml of milk before and after each feeding for fat analysis
- The subject signed the Informed Consent Form
You may not qualify if:
- Mastitis (any breast within two weeks prior enrolment)
- Engorgement (any breast within two weeks prior enrolment)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medela AG
Baar, Canton of Zug, 6341, Switzerland
Related Publications (1)
Sakalidis VS, Ivarsson L, Haynes AG, Jager L, Scharer-Hernandez NG, Mitoulas LR, Prime DK. Breast shield design impacts milk removal dynamics during pumping: A randomized controlled non-inferiority trial. Acta Obstet Gynecol Scand. 2020 Nov;99(11):1561-1567. doi: 10.1111/aogs.13897. Epub 2020 Jun 5.
PMID: 32401335DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lennart Ivarsson, PhD
Employee
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 15, 2017
First Posted
March 27, 2017
Study Start
March 31, 2017
Primary Completion
September 30, 2017
Study Completion
December 19, 2017
Last Updated
February 10, 2020
Record last verified: 2018-02
Data Sharing
- IPD Sharing
- Will not share